01 September 2026, London: There is a question sitting underneath every pesticide ban announcement, and carbosulfan’s slow march toward prohibition raises it more sharply than most: was this chemical always this dangerous, and we simply chose to accept the risk because we needed it, or did the danger only become visible over time, as science caught up with what industry had already put into millions of fields?
The honest answer is neither story on its own. It is a mix of both, and understanding which parts were known and which parts were not is the difference between learning something useful from carbosulfan’s history and simply feeling vaguely alarmed by it.
The Danger Was Never a Secret. It Was the Design.
Start with the part that is easy to get wrong: carbosulfan’s toxicity was not a hidden defect discovered decades later. It was the whole point of the molecule, on purpose, from day one.
Carbosulfan was engineered in the 1970s by chemists at FMC Corporation as a “pro-carbamate,” a derivative of carbofuran designed to stay relatively inert until it entered a target insect’s body, where it would convert into the far more toxic carbofuran and do its lethal work. The patent filings from that era describe this mechanism plainly: a compound built to retain carbofuran’s insecticidal punch while reducing acute mammalian toxicity in the applied product. In other words, the scientists who invented carbosulfan knew, because they designed it this way, that it would become carbofuran once absorbed. That is not a discovery. That is the product specification.
So when regulators around the world evaluated carbosulfan for registration through the 1980s, including the WHO’s Joint Meeting on Pesticide Residues, which produced its first toxicological monograph on the compound in 1984, they were not working from incomplete data about a mystery chemical. They knew what carbosulfan was, how it worked, and what it turned into inside a living body. What they had, by the standards of that era, was a molecule that tested less acutely toxic than carbofuran in the concentrations and formulations submitted for approval, and that promised fewer of the bird-kill incidents that had made carbofuran granules notorious through the 1970s and 80s.
What Changed Was Not the Chemistry. It Was the Evidence About Real-World Outcomes.
If the mechanism was known from the start, what actually shifted over forty years to turn carbosulfan from an approved, actively marketed insecticide into a molecule now banned across the EU, Sri Lanka, Vietnam, and soon possibly India?
Largely, it was the accumulation of field-level and clinical evidence that laboratory toxicology alone could not have predicted. The clearest example comes from Sri Lanka, which has tracked pesticide self-poisoning cases with unusual rigor because the country has, for decades, had one of the world’s highest rates of pesticide-related deaths. When clinicians compared outcomes across hundreds of poisoning cases, they found something that formal WHO hazard classifications had not anticipated: patients poisoned with carbosulfan died at a rate of 11.1 percent, more than five times higher than the 2.2 percent fatality rate for carbofuran poisoning itself, despite carbosulfan sitting in a formally less hazardous WHO toxicity class. The molecule that was supposed to be the safer alternative was, in practice, killing more of the people who were exposed to it in dangerous quantities.
That is the kind of finding that a standard laboratory LD50 study, run on rats under controlled dosing, will not reliably surface. It required real poisoning cases, hospital records, and years of comparative clinical data to expose. It is not that carbosulfan’s underlying chemistry changed between 1984 and today. It is that the evidence base about what that chemistry actually does to human beings in the field, not in a lab, matured, and it told a less reassuring story than the original approval data implied.
The same pattern holds on the ecological side. Bird, bee, fish and earthworm toxicity data has deepened considerably since the 1980s, and cumulative-exposure science, the idea that people and wildlife are routinely exposed to multiple carbamates and organophosphates at once, sharing a common mechanism of toxicity, only became a formal part of regulatory risk assessment in the early 2000s. The US EPA did not begin treating N-methyl carbamates as a cumulative risk group until 2001. Before that, each chemical was largely judged in isolation, as though a farmworker or a village well was only ever exposed to one insecticide at a time. That assumption was always false. It just took regulatory science a couple of decades to build the tools to say so with confidence.
Necessity, Not Ignorance, Kept It in the Field
None of this means carbosulfan was pushed onto farmers under false pretenses. For much of its working life, it genuinely was one of the better tools available. Carbofuran itself, its toxic parent compound, had already demonstrated its value against stem borers, sucking pests, and soil insects across rice, cotton and vegetable crops, but its direct-acting granules were killing birds in field trials and real farms alike, sometimes a single granule was enough. Carbosulfan’s pro-carbamate design was a genuine, good-faith attempt at harm reduction within the chemistry available at the time, not a cynical exercise in regulatory arbitrage.
And for farmers battling gall midge in rice or aphids in cotton, especially in regions with limited access to newer, more selective chemistries, carbosulfan filled a real gap. This is precisely the argument India’s agrochemical industry is making today: with a comparatively narrow basket of registered molecules next to markets like the EU or US, removing carbosulfan without a ready replacement risks handing the advantage back to the pest, not just to safety.
Was Carbosulfan Always Poisonous!
So, was carbosulfan always poisonous? Yes, structurally, by design, from the day it was patented. Was that poison always fully understood in its real-world consequences? No. The gap between what a 1984 toxicology dossier could show and what forty years of clinical poisoning data, ecological monitoring and cumulative-risk science would eventually reveal is the actual story here, not concealment, but the limits of the science available at the time, and the slow, evidence-driven process by which those limits get pushed back.
That is also, ultimately, the most useful lens for reading today’s pesticide debates, in India and elsewhere. The next generation of “safer” chemistries now entering fields will be judged, fairly, by the same standard carbosulfan eventually was: not by what the launch-day dossier says, but by what decades of real exposure eventually teaches us. The molecules being approved today are not necessarily less scrutinized than carbosulfan was in the 1980s. They are simply earlier in a story whose ending we cannot yet see.
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
